What do Pondimin, Redux, Baycol, etc., Have In Common?

[Guest guest]

Comments?

ps- remember to cut and paste a url to your address box if it is too

long for it to link properly...

Misty L. Trepke

http://www..com

 

What do Pondimin, Redux,Seldane, Posicor, Duracht, Hismanal, Raxar,

Rezulin, Propulsid, Lotronex, Raplon, and Baycol all have in common?

 

Answer: All are drugs that the FDA pulled off the market within the

last few years that were fraudulently approved by this criminal

Agency where corruption runs rampant.

 

I just watched a great documentary on the Public Broadcasting

System's " Frontline " program titled " Dangerous Prescription " about

how the FDA is killing Americans in unprecedented numbers in the

past 5 years due to criminality within the Agency.

 

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/hazard/

 

Congressional Pharma Stooges such as Senator Dick Durbin (S.722

Dietary Supplement Safety Act) and Congressmen Davis, Waxman, and

Dingle (HR 3377) have a lot of nerve claiming that dietary

supplements pose a threat in our society and that we need " FDA to

reign them in " when we have this heavily documented level of

corruption at the FDA which is clearly serving as a Trade

Association for the pharmaceutical industry.

 

Call your Congressman today via 202-225-3121 and complain. Tell them

to tune in this PBS documentary on the web on Sunday.

 

On Sunday, people world wide can view this show in its entirety on

at the URL above, and I encourage all of you on the IAHF list to,

and to encourage your elected officials to also- because instead of

engaging in witch hunts attacking safe dietary supplements, the

criminals who work for the world's FDA's need to be reigned in. Some

should be imprisoned for approving poisons such as these.

 

Former FDA drug reviewers who quit due to total disgust at how their

reports were censored, and altered, and how they were pressured to

change reports to make them more favorable for approval were

interviewed regarding the fraudulent approval of such dangerous

drugs as Dexfenfluoramine, Pondamin, Raxar and many others.

 

Here is an interactive Chart showing a dozen drugs that were

fraudulently approved by the FDA, then removed from the market

between 1997 and 2001. The chart names the drug, the manufacturer,

when there were approved, what the drug was prescribed for, the

adverse effects, and the date the drug was finally withdrawn from

the market.

 

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/etc/dozen.

html

 

Here is information from the PBS website about this interesting

program:

 

SAFE AND EFFECTIVE?

How good is America's drug safety system? Since 1997, more than a

dozen prescription drugs have been taken off the market due to

serious side effects -- in some cases after hundreds of injuries and

even deaths have occurred. Is the Food and Drug Administration,

which is responsible for approving and monitoring the safety of the

medications we take, up to the task? Here are excerpts from

FRONTLINE's interviews with the FDA's Steven Galson and Paul

Seligman, Public Citizen's Sidney Wolfe, and Raymond Woosley

of the University of Arizona.

 

HOW INDEPENDENT IS THE FDA?

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/hazard/ind

ependent.html

Is the FDA too close to the industry it regulates? Critics argue that

industry funding of the drug review and approval process gives

pharmaceutical companies, and their lobbyists, too much influence

over decision-making and policy. To address these issues, in

excerpts from FRONTLINE's interviews, are Public Citizen's Sidney

Wolfe, the FDA's Steven Galson, the University of Arizona's Raymond

Woosley, and pharmaceutical industry lobbyist John Kelly.

 

INTERVIEW: LEO LUTWAK, MD

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews

/lutwak.html

" The FDA is wholly dependent on trust -- on trusting [that] the

company is providing all the truth all the time, " says Leo Lutwak, a

retired FDA drug reviewer specializing in obesity. Dr. Lutwak was

the chief medical reviewer for weight-loss drugs and was at the

center of the Fen Phen controversy. In this interview, Dr. Lutwak

recalls the role he played in the review of Redux and provides

insight into the sequence of events that led to the recall of

this drug. (Since the time this interview was conducted, Lutwak has

been retained by plaintiff's counsel in the ongoing litigation

surrounding these drugs.)

 

INTERVIEW: MICHAEL ELASHOFF, PhD.

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews

/elashoff.html

 

" I think it was pretty well understood, " say former FDA scientist

Michael Elashoff, " that if you were advocating turning a drug down --

particularly if it was from a large pharmaceutical company -- that

that wouldn't be good for your career. " A drug reviewer for the FDA

from 1995 to 2000, Elashoff says he was marginalized within the

agency after he voiced his concerns about a new flu drug called

Relenza. Here, Elashoff speaks out about the culture of the FDA's

drug approval process.

 

INTERVIEW: STEVEN GALSON, MD

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews

/galson.html

 

" We think we can run a high-quality independent program, regardless

of the source of the resources, " says the FDA's Steven Galson,

acting director of the Center for Drug Evaluation and Research, " as

long as, of course, the resources aren't linked to performance goals

that are going to interfere with our independence. " In this

interview, Galson discusses the FDA's drug safety system and

explains how the Prescription Drug User Fee Act helps the FDA.

 

INTERVIEW: PAUL SELIGMAN, MD, MPH

http://www.pbs.org/wgbh/pages/frontline/shows/prescription/interviews

/seligman.html

" The fundamental point, " says Seligman, director of the FDA's Office

of Drug Safety, " is that no drug -- even having gone through this

long period of development, testing, and review -- is 100 percent

safe. " Seligman explains how his office handles adverse-event

reports from pharmaceutical companies and through the MedWatch

system, and discusses various areas in which the agency's drug

safety program could be improved.

 

International Advocates for Health Freedom

POB 10632 Blacksburg VA 24062 USA

http://www.iahf.com; http://iadsa-exposed.tripod.com

800-333-2553 N.America

540-961-0476 World